Evidence map›Paper›PMID 36851290›Full record

ArticleVaccines2023

Understanding COVID-19 Vaccine Hesitancy among Healthcare Workers in South Africa.

Gavin George, Phiwe Babalo Nota, Michael Strauss, Emma Lansdell, Remco Peters, Petra Brysiewicz, Nisha Nadesan-Reddy, Douglas Wassenaar

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Gavin GeorgeHealth Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban 4041, South Africa.ORCID 0000-0001-7258-8470
Phiwe Babalo NotaHealth Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban 4041, South Africa.ORCID 0000-0003-4393-077X
Michael StraussHealth Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban 4041, South Africa.
Emma LansdellHealth Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban 4041, South Africa.
Remco PetersResearch Unit, Foundation for Professional Development, East London 5241, South Africa.
Petra BrysiewiczSchool of Nursing & Public Health, University of KwaZulu-Natal, Durban 4041, South Africa.ORCID 0000-0001-6258-1603
Nisha Nadesan-ReddySchool of Nursing & Public Health, University of KwaZulu-Natal, Durban 4041, South Africa.
Douglas WassenaarSouth African Research Ethics Training Initiative, School of Applied Human Sciences, University of KwaZulu-Natal, Pietermaritzburg 3209, South Africa.ORCID 0000-0003-0839-9231
University of KwaZulu-Natal · ZAFoundation for Professional Development · ZALund University · SE

Funding

Developing Research Innovation, Localization and Leadership in South Africa (DRILL)D43TW010131 · FIC · UNIVERSITY OF KWAZULU-NATAL · PI BRYSIEWICZ, PETRA, MOSHABELA, MOSA · 2015 to 2019
$3.2M
FIC NIH HHS D43 TW010131FIC NIH HHS D43TW010131
6 · The paper itself

Abstract

Healthcare workers (HCWs) were the first population group offered coronavirus disease 2019 (COVID-19) vaccines in South Africa because they were considered to be at higher risk of infection and required protecting as they were a critical resource to the health system. In some contexts, vaccine uptake among HCWs has been slow, with several studies citing persistent concerns about vaccine safety and effectiveness. This study aimed to determine vaccine uptake among HCWs in South Africa whilst identifying what drives vaccine hesitancy among HCWs. We adopted a multimethod approach, utilising both a survey and in-depth interviews amongst a sample of HCWs in South Africa. In a sample of 7763 HCWS, 89% were vaccinated, with hesitancy highest among younger HCWs, males, and those working in the private sector. Among those who were hesitant, consistent with the literature, HCWs raised concerns about the safety and effectiveness of the vaccine. Examining this further, our data revealed that safety and effectiveness concerns were formed due to first-hand witnessing of patients presenting with side-effects, concern over perceived lack of scientific rigor in developing the vaccine, confidence in the body's immune system to stave off serious illness, and both a general lack of information and distrust in the available sources of information. This study, through discursive narratives, provides evidence elucidating what drives safety and effectiveness concerns raised by HCWs. These concerns will need to be addressed if HCWs are to effectively communicate and influence public behaviour. HCWs are key role players in the national COVID-19 vaccination programme, making it critical for this workforce to be well trained, knowledgeable, and confident if they are going to improve the uptake of vaccines among the general population in South Africa, which currently remains suboptimal.

Indexed as

COVID-19healthcare workersSouth Africavaccine hesitancy

Identifiers

PMID36851290
PMCPMC9966714
OpenAlexW4320496966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.